RPGLIFE Receives Order from GST Authority, Gujarat
RPG Life Sciences received an order from GST Authority, Gujarat for ₹2.04 crore related to tax period April 2021 - March 2022. The company will seek legal remedy and does not foresee material financial impact.
The company states that it does not foresee any material financial impact from the order.
The announcement is about receiving an order from the GST authority. The company intends to contest the demand and does not foresee a material financial impact.
* RPG Life Sciences has received an order from the GST Authority, Gujarat on 27 November 2025. * The order is under section 73 of the Goods and Service Tax Act, 2017 (IGST Gujarat). * The demand pertains to the tax period April 2021 - March 2022. * The total demand is ₹2,04,80,736, comprising: * Tax: ₹1,10,70,176 * Interest: ₹83,03,542 * Penalty: ₹11,07,018 * The company is perusing the order and will seek appropriate legal remedy to contest the demand. * The company does not foresee any material financial impact on account of the order.
What to do with a filing like this
RPG Life Sciences Limited filed this with the NSE as a statutory disclosure, categorised under litigation updates. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by RPG Life Sciences Limited. Read the original for the full detail.